HDL Stimulation of Endothelial Nitric Oxide Synthase A Novel Mechanism of HDL Action

2003 ◽  
Vol 13 (6) ◽  
pp. 226-231 ◽  
Author(s):  
C Mineo
2002 ◽  
Vol 364 (3) ◽  
pp. 863-868 ◽  
Author(s):  
Sabine WAGNER ◽  
Klaus GROSCHNER ◽  
Bernd MAYER ◽  
Kurt SCHMIDT

Stimulation of endothelial cells with receptor agonists leads to an activation of endothelial nitric oxide synthase (eNOS) that only lasts for a short duration. A more prolonged effect, however, is observed in response to non-receptor agonists, such as Ca2+ ionophores or thapsigargin (TG). To investigate the molecular mechanisms underlying the rapid deactivation of eNOS after stimulation with receptor agonists, we measured the time courses of eNOS activation and intracellular free Ca2+ concentration ([Ca2+]i) in response to bradykinin (BK) and ATP. Incubation of porcine aortic endothelial cells with BK (1μM) in the presence of 3mM extracellular Ca2+ increased [Ca2+]i from 110 to 350nM and enhanced the rate of l-[3H]citrulline formation from 0.1 to 5fmol/min. In the absence of extracellular Ca2+, the BK-induced increase in [Ca2+]i was only marginal (from 30 to 110nM) and not sufficient to activate eNOS. When Ca2+ (final concentration 3mM) was added 10min after BK, [Ca2+]i increased to 330nM within 3min, but interestingly, formation of l-[3H]citrulline was not detectable. A similar phenomenon was observed with ATP, but not with Ca2+ ionophores or TG. This indicates that stimulation of endothelial cells with receptor agonists leads to desensitization of eNOS, which renders the enzyme insensitive to activation by subsequent increases in [Ca2+]i. However, when ATP was added to BK-pretreated cells or, conversely, BK to ATP-pretreated cells, activation of eNOS was comparable with that of untreated cells, suggesting that BK and ATP affect different pools of eNOS. The desensitization of eNOS was reversible, since removal of ATP or BK from the incubation buffer restored the response to the respective agonist within 20min. In addition to the transient Ca2+ signal, desensitization of eNOS may represent a further mechanism by which endothelial cells rapidly terminate receptor-dependent NO formation.


Nitric Oxide ◽  
2003 ◽  
Vol 9 (2) ◽  
pp. 95-102 ◽  
Author(s):  
Thomas Wallerath ◽  
Thomas Kunt ◽  
Thomas Forst ◽  
Ellen I Closs ◽  
Ralf Lehmann ◽  
...  

Author(s):  
Chi-Ming Wei ◽  
Margarita Bracamonte ◽  
Shi-Wen Jiang ◽  
Richard C. Daly ◽  
Christopher G.A. McGregor ◽  
...  

Nitric oxide (NO) is a potent endothelium-derived relaxing factor which also may modulate cardiomyocyte inotropism and growth via increasing cGMP. While endothelial nitric oxide synthase (eNOS) isoforms have been detected in non-human mammalian tissues, expression and localization of eNOS in the normal and failing human myocardium are poorly defined. Therefore, the present study was designed to investigate eNOS in human cardiac tissues in the presence and absence of congestive heart failure (CHF).Normal and failing atrial tissue were obtained from six cardiac donors and six end-stage heart failure patients undergoing primary cardiac transplantation. ENOS protein expression and localization was investigated utilizing Western blot analysis and immunohistochemical staining with the polyclonal rabbit antibody to eNOS (Transduction Laboratories, Lexington, Kentucky).


Sign in / Sign up

Export Citation Format

Share Document